Sunday, November 21, 2010

New Drug Shows Promise Against Certain Lung Cancers

An experimental cancer drug is proving effective in treating the lung cancers of some patients whose tumors carry a certain genetic mutation, new studies show.
Because the mutation can be present in other forms of cancer -- including a rare form of sarcoma (cancer of the soft tissue), childhood neuroblastoma (brain tumor), as well as some lymphomas, breast and colon cancers -- researchers say they are hopeful the drug, crizotinib, will prove effective in treating those cancers as well.
In one study, researchers identified 82 patients from among 1,500 patients with non-small-cell lung cancer, the most common type of lung malignancy, whose tumors had a mutation in the anaplastic lymphoma kinase (ALK) gene.
Crizotinib targets the ALK "driver kinase," or protein, blocking its activity and preventing the tumor from growing.

1 comment:

  1. Hi, I find it very refreshing to occasionally find a article such as yours with an unusual topic.
    It somehow ads to ones list of lifes experiences.Once again, thank you,
    hope to see more posts from you in the future :-)
    Hubpages Hub Creation
    Web 2.0 Submissions
    Local Business Listings